Fresh thinking, inspiration, and news from the Navihood

Mar 20, 2015

The brave new world of immuno-oncology messaging

Navicor is illuminating immuno-oncology

Immuno-oncology is one of the hottest fields in pharma today. Since being heralded as Science magazine’s 2013 “Breakthrough of the Year,” progress and enthusiasm have continued at a dizzying pace. Almost every pharmaceutical company with an oncology portfolio has pipeline products that tap into the potential of immuno-oncology. So, what’s all the buzz about? Until […]

Continue Reading
Jun 24, 2014

Our Story

At Navicor, oncology is more than a therapeutic category—it’s personal. When the life of one individual—Garnett Dezember, our founder and CEO—was touched by cancer, he pledged to create positive and lasting change in the oncology therapeutic market. In the decade since, Navicor has grown into a team of oncology experts, distinguished clinicians, and award-winning creative […]

Continue Reading